TP53 and cancer: To investigate whether mutp53 render cancer cells more susceptible to PBA treatment, we silenced p53 (Figure 1j) and found that PBA cytotoxicity was reduced in p53-silenced cells in comparison to the empty-vector treated control cells (Figure 1k,l).